Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Newswire

Comprehensive Real-Time News Feed for Teva Pharmaceutical Industries.

Results 1 - 20 of 580 in Teva Pharmaceutical Industries

  1. "Huntington's Disease - Pipeline Review, H1 2014" Is Now Available at Fast Market ResearchRead the original story

    19 hrs ago | SBWire

    ... plc, Isis Pharmaceuticals, Inc., Sangamo BioSciences, Inc., Ipsen S.A., Pfizer Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, Hadasit Medical Research Services & Development Ltd, Evotec AG, GW Pharmaceuticals plc, ...

    Comment?

  2. Sterne Agee Initiates Coverage on Teva Pharmaceutical Industries LtdRead the original story w/Photo

    21 hrs ago | AmericanBankingNews.com

    ... research reports. Analysts at National Alliance Securities initiated coverage on shares of Teva Pharmaceutical Industries Ltd (ADR) in a research note on Monday, April 7th. They set a "buy" rating and a $64.22 price target on the stock. Separately, ...

    Comment?

  3. Antares Pharma Announces Additional Patent Coverage for OTREXUPRead the original story

    23 hrs ago | Business Wire

    ... multi-use pen injectors and reusable needle-free injectors marketed as Tjet and Zomajet by Teva Pharmaceutical Industries, Ltd (Teva) and Ferring Pharmaceuticals (Ferring), respectively. Antares Pharma has a multi-product deal with Teva that ...

    Comment?

  4. New market study, "Substance (Drug) Abuse - Pipeline Review, H1 2014", has been publishedRead the original story

    23 hrs ago | PR-inside.com

    ... understanding the factors that drove them from pipeline Companies Mentioned in this Report: Teva Pharmaceutical Industries Limited, Addex Therapeutics, Snowdon Inc., Grunenthal GmbH, Reckitt Benckiser Pharmaceutical, Inc., AllTranz, Inc., ...

    Comment?

  5. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Yesterday | Business Wire

    Research and Markets: Global Testicular Cancer Drugs Market 2014-2018 With Bristol-Myers Squibb, Hospira, Teva Pharmaceutical Industries & ZIOPHARM Oncology Dominating )--Research and Markets has announced the addition of the "Global Testicular Cancer Drugs Market 2014-201... )--Research and Markets has announced the addition of the "Global ... (more)

    Comment?

  6. Teva Announces Launch of Generic LunestaA Tablets in the United StatesRead the original story

    Tuesday | Freshnews

    Teva Pharmaceutical Industries Ltd. announces the launch of the generic equivalent to Lunesta , 1, 2 and 3 mg, in the United States.

    Comment?

  7. Teva Pharmaceutical Industries Limited Announces Launch Of Generic...Read the original story

    Tuesday | BioSpace

    Teva Pharmaceutical Industries Ltd. announces the launch of the generic equivalent to LunestaA , 1, 2 and 3 mg, in the United States.

    Comment?

  8. Albany Molecular Aspires To Grow Revenue Five-Fold In As Many YearsRead the original story

    Tuesday | Seeking Alpha

    Albany Molecular recently began talking up an aggressive growth plan to increase revenues more than 5-fold to $1.35 billion by 2019.

    Comment?

  9. Generics file response to Teva in Copaxone patent fightRead the original story

    Tuesday | Lincoln Daily News

    Generic drug manufacturers on Monday asked the U.S. Supreme Court to allow a lower court ruling favoring them to take effect while the high court considers an appeal in a patent fight over Teva Pharmaceutical Industries Ltd's top-selling multiple sclerosis drug, Copaxone.

    Comment?

  10. Schizophrenia - Pipeline Review, H1 2014 - New Market Research ReportRead the original story

    Monday Apr 14 | SBWire

    ... A/S, Les Laboratoires Servier SAS, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Teva Pharmaceutical Industries Limited, Zydus Cadila Healthcare Limited, XTL Biopharmaceuticals Ltd., NuPathe Inc., Addex Therapeutics, Evotec AG, GW ...

    Comment?

  11. Market Report, "Women Infertility - Pipeline Review, H1 2014", PublishedRead the original story

    Monday Apr 14 | SBWire

    ... plc, Merck & Co., Inc., Reliance Life Sciences Pvt. Ltd., ASKA Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Limited, Zydus Cadila Healthcare Limited, IBSA Institut Biochimique SA, Pantec Biosolutions AG, Merck KGaA, Access ...

    Comment?

  12. Is Teva Pharmaceutical Industries Ltd. Destined for Greatness?Read the original story

    Monday Apr 14 | The Motley Fool

    ... follow him on Twitter, @TMFBiggles , for more news and insights. The Motley Fool recommends Teva Pharmaceutical Industries. Try any of our Foolish newsletter services free for 30 days . We Fools don't all hold the same opinions, but we all believe ...

    Comment?

  13. This Is the Toughest Part of InvestingRead the original story

    Monday Apr 14 | The Motley Fool

    ... Mine Safety Appliances, Air Products and Chemicals, Kinder Morgan, Union Pacific, McDonald's, Teva Pharmaceutical Industries, United Technologies, AFLAC, United Parcel Service, CSX, J.M. Smucker, Hasbro, Becton Dickinson, Emerson Electric, Genuine ...

    Comment?

  14. Interview of Daniel Isenberg on the Potential To Launch Contrarian...Read the original story

    Oct 2, 2013 | David squared Dalka

    Daniel Isenberg has likely written one of the most important books on entrepreneurship I've ever seen.

    Comment?

  15. Osteoarthritis Pain - Pipeline Review, H1 2014: New Research Report Available at Fast Market ResearchRead the original story

    Friday Apr 11 | SBWire

    ... Sanofi, Eli Lilly and Company, BioDelivery Sciences International, Inc., Purdue Pharma L.P., Teva Pharmaceutical Industries Limited, A. Menarini Industrie Farmaceutiche Riunite Srl, Addex Therapeutics, Nuvo Research Inc., Elite Pharmaceuticals, ...

    Comment?

  16. New Market Report Now Available: Glaucoma - Pipeline Review, H1 2014Read the original story

    Friday Apr 11 | SBWire

    ... Santen S.A.S., Kowa Company, Ltd., Merz Pharma GmbH & Co. KgaA, Ono Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, InSite Vision Incorporated, Can-Fite BioPharma Ltd., NicOx S.A., Acadia ...

    Comment?

  17. Global testicular cancer drugs market dominated by Bristol-Myers...Read the original story w/Photo

    Friday Apr 11 | PR-inside.com

    ... market. Key vendors dominating this space include Bristol-Myers Squibb Co., Hospira Inc., Teva Pharmaceutical Industries Ltd., and ZIOPHARM Oncology Inc. Other vendors mentioned in the report are Baxter International Inc., Fresenius Kabi ...

    Comment?

  18. Arthritis - Pipeline Review, H1 2014 - New Report AvailableRead the original story

    Thursday Apr 10 | SBWire

    ... Co., Ltd., Sylentis S.A., Astellas Pharma Inc., Eisai Co., Ltd., Elan Corporation, plc, Teva Pharmaceutical Industries Limited, TheraKine Ltd., Bone Medical Limited, Can-Fite BioPharma Ltd., MEI Pharma, Inc., Lexicon Pharmaceuticals, Inc., CSL ...

    Comment?

  19. "Neuroblastoma - Pipeline Review, H1 2014" PublishedRead the original story

    Thursday Apr 10 | SBWire

    ... plc, Gamida Cell Ltd., BioLineRx, Ltd., Novartis AG, Chugai Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Limited, Progenics Pharmaceuticals, Inc., Celgene Corporation, AEterna Zentaris Inc., Lixte Biotechnology Holdings, Inc., Lorus ...

    Comment?

  20. Market Report, "Israel Pharmaceuticals & Healthcare Report Q2 2014", PublishedRead the original story

    Thursday Apr 10 | SBWire

    ... from 57 out of 100 in Q114. Key Trends And Developments In February 2014, Israeli drugmaker Teva Pharmaceutical Industries concluded its tender offer for all outstanding shares in US-based speciality pharmaceutical company NuPathe on February 21. In ...

    Comment?